Biblio

Found 174 results
Author Keyword Title Type [ Year(Asc)]
Filters: First Letter Of Keyword is H  [Clear All Filters]
2015
A. M. Poveda, Selle, F., Hilpert, F., Reuss, A., Savarese, A., Vergote, I. B., Witteveen, P., Bamias, A., Scotto, N., Mitchell, L., and Pujade-Lauraine, E., Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial., J Clin Oncol, vol. 33, no. 32, p. 3838, 2015.
R. T. Penson, Huang, H. Q., Wenzel, L. B., Monk, B. J., Stockman, S., Long, H. J., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J. A., Leitao, M. M., Method, M., Michael, H., and Tewari, K. S., Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240)., Lancet Oncol, vol. 16, no. 3, pp. 301-11, 2015.
S. Mahner, Meier, W., du Bois, A., Brown, C., Lorusso, D., Dell'Anna, T., Cretin, J., Havsteen, H., Bessette, P., Zeimet, A. G., Vergote, I. B., Vasey, P. A., Pujade-Lauraine, E., Gladieff, L., and Ferrero, A., Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial., Eur J Cancer, vol. 51, no. 3, pp. 352-8, 2015.
D. K. Gaffney, Suneja, G., Ryu, S. Young, McCormick, M., Plante, M., Mileshkin, L. R., Small, W., Bacon, M., Stuart, G. C. E., and Kitchener, H. C., The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup., Int J Radiat Oncol Biol Phys, vol. 92, no. 3, pp. 506-8, 2015.
C. Khoon Lee, Lord, S., Grunewald, T., Gebski, V., Hardy-Bessard, A. - C., Sehouli, J., Woie, K., Heywood, M., Schauer, C., Vergote, I. B., Scambia, G., Ferrero, A., Harter, P., Pujade-Lauraine, E., and Friedlander, M. Leonard, Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial., Gynecol Oncol, vol. 136, no. 1, pp. 18-24, 2015.
A. M. Oza, Cook, A. D., Pfisterer, J., Embleton, A. C., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G. B., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T. - W., Rustin, G. J. S., Joly, F., Mirza, M. R., Plante, M., Quinn, M., Poveda, A. M., Jayson, G. C., Stark, D., Swart, A. Marie, Farrelly, L., Kaplan, R. S., Parmar, M. K. B., and Perren, T. J., Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial., Lancet Oncol, vol. 16, no. 8, p. 936, 2015.
2014
E. Pujade-Lauraine, Hilpert, F., Weber, B., Reuss, A., Poveda, A. M., Kristensen, G. B., Sorio, R., Vergote, I. B., Witteveen, P., Bamias, A., Pereira, D., Wimberger, P., Oaknin, A., Mirza, M. Raza, Follana, P., Bollag, D., and Ray-Coquard, I., Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial., J Clin Oncol, vol. 32, no. 13, p. 1308, 2014.
G. Emons, Gorchev, G., Sehouli, J., Wimberger, P., Stähle, A., Hanker, L., Hilpert, F., Sindermann, H., Grundker, C., and Harter, P., Efficacy and safety of AEZS-108 (INN: zoptarelin doxorubicin acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: a multicenter phase II trial of the AGO-study group (AGO G, Gynecol Oncol, vol. 133, pp. 427-32, 2014.
N. Simon Reed, Gomez-Garcia, E., Gallardo-Rincon, D., Barrette, B. A., Baumann, K. H., Friedlander, M. Leonard, Kichenadasse, G., Kim, J. - W., Lorusso, D., Mirza, M. Raza, and Ray-Coquard, I., Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S35-41, 2014.
H. Fujiwara, Yokota, H., Monk, B. J., Treilleux, I., Devouassoux-Shisheboran, M., Davis, A., Kim, J. - W., Mahner, S., Stany, M., Pignata, S., Ray-Coquard, I., and Fujiwara, K., Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S96-101, 2014.
A. Okamoto, Glasspool, R. M., Mabuchi, S., Matsumura, N., Nomura, H., Itamochi, H., Takano, M., Takano, T., Susumu, N., Aoki, D., Konishi, I., Covens, A., Ledermann, J. A., Mezzanzanica, D., Mezzazanica, D., Steer, C., Millan, D., McNeish, I. A., Pfisterer, J., Kang, S., Gladieff, L., Bryce, J., and Oza, A. M., Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S20-5, 2014.
K. Hasegawa, Nagao, S., Yasuda, M., Millan, D., Viswanathan, A., Glasspool, R. M., Devouassoux-Shisheboran, M., Covens, A., Lorusso, D., Kurzeder, C., Kim, J. - W., Gladieff, L., Bryce, J., Friedlander, M. Leonard, and Fujiwara, K., Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S90-5, 2014.
F. Amant, Floquet, A., Friedlander, M. Leonard, Kristensen, G. B., Mahner, S., Nam, E. Ji, Powell, M. A., Ray-Coquard, I., Siddiqui, N. Ahmad, Sykes, P., Westermann, A. M., and Seddon, B., Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S67-72, 2014.
P. Pautier, Nam, E. Ji, Provencher, D. M., Hamilton, A. L., Mangili, G., Siddiqui, N. Ahmad, Westermann, A. M., Reed, N. Simon, Harter, P., and Ray-Coquard, I., Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S73-7, 2014.
J. A. Ledermann, Luvero, D., Shafer, A., O'Connor, D., Mangili, G., Friedlander, M. Leonard, Pfisterer, J., Mirza, M. R., Kim, J. - W., Alexandre, J., Oza, A. M., and Brown, J., Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinoma., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S14-9, 2014.
M. Leonard Friedlander, Covens, A., Glasspool, R. M., Hilpert, F., Kristensen, G. B., Kwon, S., Selle, F., Small, W., Witteveen, E., and Russell, P., Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S78-82, 2014.
P. Harter, Gershenson, D., Lhomme, C., Lecuru, F., Ledermann, J. A., Provencher, D. M., Mezzanzanica, D., Quinn, M., Maenpaa, J. U., Kim, J. - W., Mahner, S., Hilpert, F., Baumann, K. H., Pfisterer, J., and du Bois, A., Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S5-8, 2014.
C. Gourley, Farley, J., Provencher, D. M., Pignata, S., Mileshkin, L. R., Harter, P., Maenpaa, J. U., Kim, J. - W., Pujade-Lauraine, E., Glasspool, R. M., Ray-Coquard, I., and Gershenson, D., Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S9-13, 2014.
N. Simon Reed, Pautier, P., Åvall-Lundqvist, E., Choi, C. - H., du Bois, A., Friedlander, M. Leonard, Fyles, A., Kichenadasse, G., Provencher, D. M., and Ray-Coquard, I., Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S30-4, 2014.
I. Ray-Coquard, Brown, J., Harter, P., Provencher, D. M., Fong, P. C., Maenpaa, J. U., Ledermann, J. A., Emons, G., Rigaud, D. Berton, Glasspool, R. M., Mezzanzanica, D., and Colombo, N., Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S42-7, 2014.
J. Brown, Friedlander, M. Leonard, Backes, F. J., Harter, P., O'Connor, D. M., Rouge, Tde la Mott, Lorusso, D., Maenpaa, J. U., Kim, J. - W., Tenney, M. E., and Seckl, M. J., Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S48-54, 2014.
T. Satoh, Takei, Y., Treilleux, I., Devouassoux-Shisheboran, M., Ledermann, J. A., Viswanathan, A., Mahner, S., Provencher, D. M., Mileshkin, L. R., Åvall-Lundqvist, E., Pautier, P., Reed, N. Simon, and Fujiwara, K., Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S102-8, 2014.

Pages